Disease Area Diagnostics & prognostics, Pain & critical care

When Minutes Matter

Sepsis is one of the most time-critical diagnoses a hospital can make. In the most severe cases, it’s estimated that patients’ likelihood of survival decreases by 7.6 percent each hour that passes without effective treatment (1). But with common symptoms like fever and pain, it can be difficult to conclusively identify sepsis in a timely manner.

The lab-on-a-chip system that uses a patient’s immune response to diagnose sepsis.Credit: Janet Sinn-Hanlon

Fortunately, science is on the case. Two groups of researchers have recently published tests that promise rapid, reliable diagnosis of sepsis: one, a new PCR-based method, and two, a portable lab-on-a-chip device.

The first, a TaqMan-based multiplex real-time PCR detection system, probes conserved regions of the 16S rDNA gene in 10 common bacterial pathogens (2). It not only detects the organisms causing sepsis, but also positively identifies them in a matter of hours, ensuring that patients can receive appropriate antibiotic treatment as soon as possible – and freeing doctors from the need to wait a day or more for blood cultures to provide the same information.

The second test takes a unique approach – instead of looking for the cause of infection, it detects the patient’s immune response (3). How? The device takes a complete white blood cell count, a neutrophil count, and measures levels of the CD64 neutrophil cell surface marker. As the immune response increases, so do these numbers, giving doctors a rapid heads-up that the patient’s condition is deteriorating. In some cases, the immune response can spot sepsis even before the causative pathogen is detectable in the blood.

“We think we need both approaches,” said Rashid Bashir, senior author on the latter study. “Detect the pathogen, but also monitor the immune response. (4)”

Receive content, products, events as well as relevant industry updates from The Translational Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. “New test to rapidly diagnose sepsis”, (2017). Available at: bit.ly/2uaocaU. Accessed August 4, 2017.
  2. CF Liu et al., “Rapid diagnosis of sepsis with TaqMan-based multiplex real-time PCR”, J Clin Lab Anal, [Epub ahead of print] (2017). PMID: 28512861.
  3. U Hassan et al., “A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification”, Nat Commun, 8, 15949 (2017). PMID: 28671185.
  4. L Ahlberg, “Quick test finds signs of sepsis in a single drop of blood”, (2017). Available at: bit.ly/2vwc8Ai. Accessed August 4, 2017.
About the Author
Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

Related Solutions
Powering Proteomics: E-book

| Contributed by SomaLogic

Tools & Techniques Diagnostics & prognostics
SERS for Label-Free Biosensing

| Contributed by Ocean Optics

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register